0001485003-21-000027.txt : 20210223
0001485003-21-000027.hdr.sgml : 20210223
20210223172131
ACCESSION NUMBER: 0001485003-21-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210219
FILED AS OF DATE: 20210223
DATE AS OF CHANGE: 20210223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cannell Thomas R
CENTRAL INDEX KEY: 0001637822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 21666870
MAIL ADDRESS:
STREET 1: C/O SESEN BIO, INC.
STREET 2: 245 FIRST STREET, SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_161411886972774.xml
FORM 4
X0306
4
2021-02-19
0
0001485003
Sesen Bio, Inc.
SESN
0001637822
Cannell Thomas R
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Employee Stock Option (Right to Buy)
3.17
2021-02-19
4
A
0
2000000
0
A
2031-02-19
Common Stock
2000000.0
2000000
D
On February 19, 2021, the reporting person was awarded options to purchase 2,000,000 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months commencing on January 1, 2021 over four years provided the reporting person is employed by the Company at each such vesting date.
/s/ Thomas R. Cannell
2021-02-23